Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron supplementation and multiple micronutrient powders for anaemia prevention in Bangladeshi infants
ACTRN12617000660381Phase 3Completed
- Sponsor
- University of Melbourne
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Iron in anaemia and iron deficiency anemia (IDA) (3 arms), sponsored by University of Melbourne. Primary endpoint: Cognitive development. Started Jul 2017; status: completed.
02
Drugs
Iron
03
Conditions
anaemiairon deficiency anemia (IDA)
Beyond the preview
Go deeper on ACTRN12617000660381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000660381.